Form 8-K CASSAVA SCIENCES INC For: Jul 01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Jones Trading Downgrades Cassava Sciences (SAVA) to Hold, 'Multiple Uncertainties'
July 1, 2024 9:43 AM EDTJones Trading analyst Soumit Roy downgraded Cassava Sciences (NASDAQ: SAVA) from Buy to Hold.
The analyst comments "Following the federal grand jury indictment of the former consultant of Cassava Sciences, Dr. Hoau-Yan Wang, last Friday (link), and today's 8-K (link) mentioning the... More
Cassava Sciences (SAVA) Provides Update on Government Investigations
July 1, 2024 8:09 AM EDTCassava Sciences (NASDAQ: SAVA) disclosed:
Item 8.01. Other Events.
Update on Government Investigations
Cassava Sciences, Inc. (Cassava or the Company) has been engaging with the U.S. Department of Justice (the DOJ) and the U.S. Securities and Exchange Commission (the SEC) in connection with ongoing investigations into the Company and two senior employees of the Company. Cassava is cooperating with the DOJ and SEC in connection with these investigations.
In the course of ongoing discussions with the SEC regarding the Companys Phase 2b study of simufilam in Alzheimers... More
